Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium 24 November
Lilly to present data from two positive Phase 3 studies of Jaypirca in chronic lymphocytic leukemia at the 2025 American Society of Hematology Annual Meeting 24 November
